StopDown
Aignosis logo
Funding · 1 October 2026Aignosis₹4 CrChild autism screeningaignosis.in ↗

Aignosis raises ₹4 crore seed round

By · Editor ·

SeedJaipurFounded 2024
  • Aignosis is a Jaipur healthtech startup that screens children for autism signs using a laptop webcam and computer vision
  • Antler, Nikhil Kamath and angels including Varun Dua and IIMA Ventures put in ₹4 crore
  • It will widen screening across India, aiming for at least one lakh screenings by the end of FY27

What happened

  • Aignosis raised ₹4 crore in seed funding.
  • Antler and Nikhil Kamath led the round.
  • Angels and IIMA Ventures also joined.
  • Funds will expand its screening platform across India.

Why it matters

  • Early signs of autism are often missed, and specialists are scarce.
  • A webcam-based test makes early screening cheaper and available in schools and primary health centres.

The business

  • Aignosis sells an AI-based autism screening tool that checks young children in about 5 minutes.
  • Buyers are clinics, paediatricians, government health centres and schools that run screening for children.
  • It works through a clinic-in-clinic model, placing its screening set-up inside partner clinics.
  • It has rolled out in 20+ government primary health centres in Rajasthan, and works with a pharma firm whose field staff help run screening camps.
  • It reports 8,000+ screenings so far and aims for 1 lakh (100,000) by the end of FY27.
  • It is based in Jaipur and was founded in 2024.

The founders

Raksheet Jain

Co-founder
in
  • B.Tech in Artificial Intelligence from NMIMS, Mumbai; builds early-intervention tools for autism and developmental disorders.

Divyansh Mangal

Co-founder
in
  • Physicist turned AI engineer; the idea grew out of research at his father's childcare centre.

Who put in money

In numbers

8,000+Screenings done · 2026
20+Government health centres · 2026
₹4 CrSeed round · 2026

What happens next

  • Reach one lakh screenings by end of FY27
  • Start operations in about 125 schools with Apollo Shines

Earlier rounds

  • 2025-01 · Pre-seed · ₹1 Cr
  • 2026-10 · Seed · ₹4 Cr

Up against

Spectrum AIFrontera HealthDAS HealthBlueSavantMindMetric.ai

Words to know

CDSCO
India's drug and medical device regulator

The numbers around it

Aignosis has 2 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
24 January 2025Pre-seed₹1 CrUndefined

Healthcare & Life Sciences in October 2026: 20 rounds with a disclosed amount, $242 million in all; the biggest was Linux Laboratories ($70M). Every sector this year →

Read it as a card in the app

Terms in this story

  • Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
  • Financial year: An Indian financial year runs from 1 April to 31 March, and it is named after the year it ends. FY26 means April 2025 to March 2026. Startup results for a year arrive months after it closes, so a November 2026 story may still be about FY25.

Everything on Aignosis → · All startup news on 1 October 2026 →

Is this Aignosis? Get your “Featured on StopDown” badge →